Shiseido has signed a binding agreement to sell its Chinese subsidiary, Shiseido Liyuan Cosmetics (SLC), to an investor consortium led by Hong Kong-based private equity firm IDG Capital. The subsidiary makes and sells the Aupres brand in China. Financial terms were not disclosed. The deal is expected to close between the fourth quarter of 2026 and the first quarter of 2027, subject to regulatory approvals, including in China.
The sale is part of Shiseido’s push to improve profitability and capital efficiency under its 2030 Medium-Term Strategy. Shiseido says it wants to drive sustainable growth and strengthen its competitiveness in China by focusing management resources on areas where it enjoys the greatest competitive advantage. The company says SLC requires continued investment in product innovation and digital capabilities. The divestment allows the group to concentrate on priority brands and higher-growth opportunities. China remains a strategically important market, Shiseido says, describing it as attractive and dynamic as e-commerce expands, consumer behavior changes and diverse market participants emerge.
Ownership and handover
SLC was established in 1991 as a joint venture with Beijing Liyuan, a subsidiary of Yiqing Group owned by the Beijing Municipal Government. It has sold the C-beauty brand Aupres since 1994. The current joint venture agreement is set to expire in December 2026, and the parties agreed not to renew it. On September 1, 2026, Shiseido acquired Beijing Liyuan’s 35% stake, giving it full ownership ahead of the sale.
Under the transaction, funds managed by IDG Capital will take 95% of the equity through two special purpose vehicles, while a limited partnership enterprise set up mainly by SLC’s new management team will hold the remaining 5%. The deal includes SLC’s Beijing factory and production equipment. Shiseido believes independent operation under IDG will support SLC’s sustainable growth and brand value.
Transitional support
To ensure a smooth handover, Shiseido will license the intellectual property rights IDG needs to run the business. For a specified period after the transfer, Shiseido will provide ongoing support on new product development, technical assistance for the stable supply of existing products, and continued supply of raw materials and selected products. The company says the arrangements aim to maintain SLC’s innovation capabilities, product quality and business continuity.
The divestment comes days after Shiseido reported a 124.3% jump in core operating profit for the third quarter of 2026 to ¥67.5 billion (US$422.13 million). The recovery was attributed to restructuring, cost cuts and improved margins rather than strong product demand; like-for-like sales grew 0.7%. Shiseido raised its full-year core operating profit forecast from ¥59 billion (US$433 million) to ¥87 billion (US$546 million) on the back of those results.
The agreement places SLC under new majority ownership while keeping Shiseido involved through licensing and transitional supply arrangements. It also marks another step in the group’s effort to reshape its portfolio around businesses where it sees stronger competitive advantage.
